Croda International Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Croda International wird ein jährliches Gewinn- und Umsatzwachstum von 25% bzw. 4.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 25.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.7% betragen.
Wichtige Informationen
25.0%
Wachstumsrate der Gewinne
25.20%
EPS-Wachstumsrate
| Chemicals Gewinnwachstum | 39.3% |
| Wachstumsrate der Einnahmen | 4.8% |
| Zukünftige Eigenkapitalrendite | 11.74% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 13 May 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Narrativ-Update • May 17
CRDA: Mixed Broker Upgrades And Execution Risks Will Shape Future P/E Expectations
Analysts have adjusted their price targets on Croda International to around £32.80. This reflects updated assumptions on revenue growth, profit margins and future P/E multiples following a series of recent rating upgrades and target tweaks across the Street.
Narrativ-Update • May 01
CRDA: Cluster Of Recent Upgrades Will Support Re Rating Potential
The updated analysis trims Croda International's fair value estimate slightly to £47.67 from £47.96, as analysts factor in recent target changes and upgrades that reflect adjusted assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Croda International has leaned constructive, with several bullish analysts adjusting ratings and targets in quick succession.Narrativ-Update • Apr 17
CRDA: Mixed Broker Upgrades And Execution Risks Will Shape Fair Value Outlook
Analysts have raised their fair value estimate for Croda International from £23.00 to £28.65, citing recent upgrades, higher price targets, and updated assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Croda International shows a mix of supportive and cautious views, with several firms revisiting their ratings and price targets in quick succession.Narrativ-Update • Apr 02
CRDA: Recent Upgrades And Higher 3,280 Price Level Will Support Re Rating
Analysts have nudged their fair value estimate for Croda International slightly lower to about £47.96 from £48.16, reflecting modest adjustments to discount rate, revenue growth, profit margin and future P/E assumptions, alongside mixed but generally constructive recent research, including both target cuts and upgrades. Analyst Commentary Recent Street research on Croda International has leaned constructive, with several bullish analysts updating their views through rating changes and revised price targets.Narrativ-Update • Mar 19
CRDA: Higher Price Move To 3,280 And Modest P/E Reset Signal Upside
Narrative Update The analyst price target for Croda International has been raised to £3,280, an increase of £250. Analysts reference recent target moves from major banks, along with small adjustments to revenue growth, profit margin, discount rate and future P/E assumptions.Narrativ-Update • Mar 05
CRDA: Higher Price References And Modest P/E Reset Will Support Upside Potential
Narrative Update The analyst price target for Croda International has been raised. Our fair value estimate has moved slightly higher to reflect recent increases in Street targets to around £32 per share, supported by analysts pointing to updated assumptions on discount rates, revenue growth, profit margins and future P/E expectations.
Narrativ-Update • Feb 19
CRDA: Higher Fair Value Assumptions Will Drive Reappraisal Of Margin Resilience
Analysts have raised their price target on Croda International by £4.00. This reflects updated assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E following recent research updates.Narrativ-Update • Feb 05
CRDA: Refined Assumptions And Lower P/E Will Support Higher Share Price
Analysts have trimmed their price target for Croda International by a small amount, reflecting updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. Valuation Changes Fair Value: trimmed slightly from £48.67 to £48.04 per share.Narrativ-Update • Jan 21
CRDA: Activist Pressure Will Drive Reappraisal Of Margin Resilience And Future Re Rating
Analysts have trimmed their price target for Croda International to £34.02 from £34.46, reflecting slightly more cautious assumptions on revenue growth and profit margin, along with a modestly higher discount rate and a higher future P/E multiple. Valuation Changes Fair Value Estimate: trimmed slightly to £34.02 from £34.46.Analyseartikel • Jan 21
Is There An Opportunity With Croda International Plc's (LON:CRDA) 26% Undervaluation?
Key Insights Croda International's estimated fair value is UK£35.97 based on 2 Stage Free Cash Flow to Equity Current...Narrativ-Update • Jan 06
CRDA: Refreshed Q4 Guidance And Earnings Outlook Will Support Higher Share Price
Croda International's updated analyst price target has moved slightly higher, with recent revisions in the range of £30.50 to £33.00 per share, supported by analysts' refreshed assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent research shows a cluster of modestly higher fair value views for Croda International, with price targets in a relatively tight range of £30.50 to £33.00 per share.Analyseartikel • Jan 06
Croda International Plc's (LON:CRDA) Popularity With Investors Is Clear
With a price-to-earnings (or "P/E") ratio of 27.2x Croda International Plc ( LON:CRDA ) may be sending very bearish...Narrativ-Update • Dec 17
CRDA: Activist Pressure Will Drive Future Reappraisal Of Margin Resilience
The analyst price target for Croda International has edged higher to approximately £31.00. This reflects modest improvements in forecast growth and valuation multiples as analysts point to stabilizing end markets and potential upside from strategic and activist driven initiatives, despite mixed target revisions across the Street.Analyseartikel • Dec 05
Should You Investigate Croda International Plc (LON:CRDA) At UK£26.70?
Croda International Plc ( LON:CRDA ), is not the largest company out there, but it received a lot of attention from a...Narrativ-Update • Dec 03
CRDA: Activist Pressure Will Drive A Reappraisal Of Margin Resilience
Analysts have nudged up their price target on Croda International by about £1, placing it in the low £30s per share. They point to a stabilizing outlook, reflected in modestly higher Street targets and expectations that prior commoditization concerns may have been overstated.Analyseartikel • Nov 20
Is Croda International (LON:CRDA) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Narrativ-Update • Nov 18
CRDA: Activist Pressure And Commoditization Concerns Will Shape The Next Share Move
Croda International's analyst price target has seen a modest upward revision to 3,150 GBp from 3,000 GBp. This reflects analysts' view that recent sector updates and firm-specific catalysts support a slightly higher fair value for the shares. Analyst Commentary Recent research updates on Croda International have highlighted a mix of optimism and caution.Narrativ-Update • Nov 03
CRDA: Activist Pressure And Sector Outlook Will Drive Share Performance This Year
Croda International's analyst price target has been modestly raised, with the new consensus target increasing to approximately £31.00 from £30.00. Analysts cite slight improvements in revenue growth expectations and a lower discount rate as reasons for the update.Narrativ-Update • Oct 20
Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America
Croda International's analyst consensus price target has seen a modest uptick, rising by £0.50 to £31.00. Analysts cite improved profit margins as offsetting softer revenue growth expectations.Analyseartikel • Oct 06
Croda International (LON:CRDA) Will Be Hoping To Turn Its Returns On Capital Around
To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...Narrativ-Update • Oct 03
Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America
Analysts have revised Croda International's price target downward from £36.00 to £31.00, citing shifts in fair value and an improving revenue growth outlook. Ongoing activist pressures are seen as a potential positive for shares despite persistent margin concerns.Analyseartikel • Sep 18
Croda International Plc's (LON:CRDA) P/E Is On The Mark
With a price-to-earnings (or "P/E") ratio of 25.7x Croda International Plc ( LON:CRDA ) may be sending very bearish...Narrativ-Update • Sep 14
Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America
Croda International’s consensus price target saw a modest reduction to £35.23 as both future P/E and revenue growth expectations remained stable. What's in the News Croda International is prioritizing organic investment with a focus on higher returns, risk management, and faster cash payback, while reducing CapEx as a percentage of sales from 2026 onwards.Analyseartikel • Aug 15
Here's Why Croda International (LON:CRDA) Can Manage Its Debt Responsibly
LSE:CRDA 1 Year Share Price vs Fair Value Explore Croda International's Fair Values from the Community and select yours...Analyseartikel • Jul 12
Croda International Plc's (LON:CRDA) Intrinsic Value Is Potentially 35% Above Its Share Price
Key Insights Croda International's estimated fair value is UK£40.28 based on 2 Stage Free Cash Flow to Equity Croda...
Neues Narrativ • Mar 02
Acquisition Of Solus Biotech And Asian Expansion Will Strengthen Future Outlook
Strengthening local relationships and strategic acquisitions, particularly in Asia, should drive revenue through higher prices and increased manufacturing capacity.Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2028 | 1,943 | 247 | 249 | 351 | 11 |
| 12/31/2027 | 1,857 | 215 | 211 | 318 | 13 |
| 12/31/2026 | 1,775 | 177 | 153 | 269 | 13 |
| 12/31/2025 | 1,699 | 62 | 167 | 287 | N/A |
| 9/30/2025 | 1,684 | 101 | 119 | 254 | N/A |
| 6/30/2025 | 1,668 | 140 | 72 | 221 | N/A |
| 3/31/2025 | 1,648 | 149 | 105 | 270 | N/A |
| 12/31/2024 | 1,628 | 159 | 138 | 319 | N/A |
| 9/30/2024 | 1,629 | 161 | 163 | 354 | N/A |
| 6/30/2024 | 1,630 | 163 | 189 | 388 | N/A |
| 3/31/2024 | 1,662 | 167 | 169 | 363 | N/A |
| 12/31/2023 | 1,695 | 171 | 149 | 338 | N/A |
| 9/30/2023 | 1,769 | 182 | 172 | 355 | N/A |
| 6/30/2023 | 1,843 | 194 | 196 | 373 | N/A |
| 3/31/2023 | 1,966 | 422 | 176 | 340 | N/A |
| 12/31/2022 | 2,089 | 649 | 156 | 308 | N/A |
| 9/30/2022 | 2,086 | 680 | 151 | 297 | N/A |
| 6/30/2022 | 2,083 | 711 | 145 | 286 | N/A |
| 3/31/2022 | 1,986 | 516 | 167 | 317 | N/A |
| 12/31/2021 | 1,890 | 321 | 189 | 348 | N/A |
| 9/30/2021 | 1,771 | 284 | 166 | 322 | N/A |
| 6/30/2021 | 1,651 | 247 | 144 | 296 | N/A |
| 3/31/2021 | 1,521 | 224 | 155 | 291 | N/A |
| 12/31/2020 | 1,390 | 202 | 166 | 287 | N/A |
| 9/30/2020 | 1,363 | 204 | N/A | N/A | N/A |
| 6/30/2020 | 1,336 | 207 | 181 | 299 | N/A |
| 3/31/2020 | 1,357 | 216 | 187 | 301 | N/A |
| 12/31/2019 | 1,378 | 224 | 193 | 304 | N/A |
| 9/30/2019 | 1,388 | 230 | N/A | N/A | N/A |
| 6/30/2019 | 1,399 | 235 | N/A | 278 | N/A |
| 3/31/2019 | 1,393 | 237 | N/A | 270 | N/A |
| 12/31/2018 | 1,387 | 239 | N/A | 262 | N/A |
| 9/30/2018 | 1,378 | 241 | N/A | 265 | N/A |
| 6/30/2018 | 1,369 | 244 | N/A | 269 | N/A |
| 3/31/2018 | 1,371 | 241 | N/A | 266 | N/A |
| 12/31/2017 | 1,373 | 237 | N/A | 263 | N/A |
| 9/30/2017 | 1,358 | 226 | N/A | 267 | N/A |
| 6/30/2017 | 1,342 | 214 | N/A | 272 | N/A |
| 3/31/2017 | 1,293 | 206 | N/A | 268 | N/A |
| 12/31/2016 | 1,244 | 197 | N/A | 264 | N/A |
| 9/30/2016 | 1,185 | 192 | N/A | 247 | N/A |
| 6/30/2016 | 1,126 | 187 | N/A | 230 | N/A |
| 3/31/2016 | 1,104 | 184 | N/A | 219 | N/A |
| 12/31/2015 | 1,082 | 181 | N/A | 208 | N/A |
| 9/30/2015 | 1,078 | 178 | N/A | 201 | N/A |
| 6/30/2015 | 1,074 | 175 | N/A | 194 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: CRDADas prognostizierte Gewinnwachstum (25% pro Jahr) liegt über der Sparquote (3.4%).
Ertrag vs. Markt: CRDADie Erträge des Unternehmens (25% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (11.4% pro Jahr).
Hohe Wachstumserträge: CRDAEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: CRDADie Einnahmen des Unternehmens (4.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (4.5% pro Jahr).
Hohe Wachstumseinnahmen: CRDADie Einnahmen des Unternehmens (4.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: CRDADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.7%).
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/21 08:30 |
| Aktienkurs zum Tagesende | 2026/05/21 00:00 |
| Gewinne | 2025/12/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Croda International Plc wird von 33 Analysten beobachtet. 13 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| James Knight | Barclays |
| Katie Richards | Barclays |
| Amy Lian | Barclays |